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Abstract 
  
Riboswitches are RNA molecules which respond to specific stimuli by turning on or off 
transcription or translation. The aptamer domain of the ​xpt-pbuX​ riboswitch in ​B. subtilis​ has a 
three-dimensional structure with a specific binding site for guanine. When guanine is bound, the 
expression platform forms a three-dimensional structure which inhibits transcription of 
downstream purine synthesis genes. In this work, polyethylene glycol (PEG) was conjugated to 
position nine of guanine. This will potentially increase the solubility of guanine in solvents such 
as dimethyl sulfoxide, making it easier to use for assays. The PEGylated guanine will be used to 
probe the xpt-pbuX riboswitch in an ​in vivo​ assay. 
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INTRODUCTION 
 
Gene expression is the process by which information, stored in the form of nucleic acid 
sequences in cell nuclei, is used as instructions to synthesize a gene product: protein or RNA. 
Gene expression consists of transcription and translation. The first step of transcription is 
initiation. An enzyme, RNA polymerase, binds to a promoter DNA sequence and DNA’s helix 
structure is unwound to expose the template DNA strand. In the next step of transcription, 
elongation, RNA is synthesized from the 5’ to 3’ end from the template DNA. The previously 
unwound and transcribed DNA then reforms its helix as the RNA polymerase moves along the 
DNA. Upon termination, RNA and RNA polymerase are released. 
 
There are five kinds of RNA. Messenger RNA (mRNA) determines the amino acid 
sequence of a polypeptide (Figure 1). Transfer RNA (tRNA) brings amino acids to the ribosome 
for translation. Ribosomal RNA (rRNA), with proteins, make up ribosomes which are 
responsible for translation of mRNA into polypeptides. Transfer-messenger RNA (tmRNA) 
found in bacteria has tRNA and mRNA properties. Small nuclear RNA (snRNA), with proteins, 
forms complexes that are used in RNA processing in eukaryotes.  
 
 
Figure 1​ Mature mRNA structure. Figure from Wikipedia [16]. 
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Translation begins when the ribosome’s small subunit docks onto a Shine-Dalgarno 
sequence just before the start codon of an mRNA molecule (Scheme 1). Then, tRNA molecules 
attached to amino acids dock at the corresponding triplet codon sequence (anticodon) on the 
mRNA molecule. This repeats many times with multiple tRNAs docking and connecting 
successive amino acids into a growing chain that elongates out of the ribosome. When the 
ribosome encounters a stop codon, it falls off the mRNA molecule and releases the protein. 
 
 
Scheme 1​ Bacterial translation initiation. Purple: mRNA. Green: ribosome. Figure 
adapted from Khan Academy [17]. 
 
It was long believed that the only role of RNA was to convert the information stored in 
DNA into proteins. However, many other functions of RNA have been elucidated, including 
enzymatic activity and regulation of gene expression. Riboswitches are ​cis​-encoded, ​cis​-acting 
regulatory segments of messenger RNA, found in many species of bacteria, which work by 
signal-dependent structure changes. Riboswitches are found in the 5’ untranslated region of 
messenger RNA and most consist of an aptamer domain and an expression platform. The 
aptamer region is highly conserved. Upon recognition of a signal by the aptamer domain, 
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typically a small ligand, a confirmation change occurs in the expression platform. The RNA 
configuration can modulate transcription or translation and thus gene expression. Riboswitches 
were initially discovered due to gene regulation without any apparent enzymatic activity, and 
could be evolutionary descendants of a pre-enzyme regulatory system.  
 
The largest class of riboswitches is metabolite-binding riboswitches, which bind a 
specific ligand with high selectivity. This class of riboswitches uses a feedback mechanism, 
regulating concentration of a specific molecule. While the majority of riboswitches function to 
repress enzymatic synthesis when the product of an enzyme is in high concentration, others 
control metal ion concentrations by repressing import pathways or triggering export pathways. 
However, riboswitches do not solely detect small molecules. Some have been found to respond 
to specific tRNA molecules as well as other parameters such as pH and temperature [1]. 
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 Scheme 2​ Modulation of gene expression via riboswitch. Figure from University of 
Colorado Boulder [18]. 
 
 
Scheme 3 ​Transcription attenuation mechanism. Black lines represent DNA. RNAP is 
RNA polymerase. Green and orange lines are RNAs that base-pair to form the terminator in the 
presence of the signal (left: transcription on) and the antiterminator in absence of the signal 
(right: transcription off). Figure from Breaker et al. [8] 
 
Riboswitch aptamers bind to their target ligands with dissociation coefficients as low as 
the mid picomolar range [8]. Upon recognition of the appropriate signal, a riboswitch will shift 
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from the “on” confirmation, which permits gene expression, to the “off” confirmation, which 
inhibits gene expression. Most riboswitches modulate gene expression via either transcription 
attenuation (cotranscriptional recognition of signal) or translation initiation (signal recognition 
can be co- or posttranscriptional). Many of those which act on transcription form a terminator 
structure in the transcription elongation complex (TEC) which causes RNA polymerase to detach 
from DNA, impeding transcription of the downstream sequence. In the absence of the 
physiological signal, the riboswitch sequence forms an antiterminator and transcription 
continues. 
 
Riboswitches which act on translation form a sequestrator helix, occluding the 
Shine-Dalgarno sequence and preventing ribosome binding. This kind of regulation is 
advantageous in that it can quickly react to its stimuli and is viable for the lifetime of the 
transcribed messenger RNA. In the absence of the signal, the riboswitch sequence forms an 
antisequestrator, the ribosome binds and translation occurs. Primer extension inhibition assays 
can be used to detect modulation of translation initiation. Rarer classes of riboswitches do not act 
by transcription attenuation or translation initiation, but rather affect accessibility of the RNA 
molecule to degradation enzymes.  
 
Various biochemical techniques can be employed to uncover riboswitch sequences and 
structures. In determining whether a riboswitch acts on transcription attenuation or translation 
initiation, purified ​in vitro​ RNA can be used to detect structure change and transcription 
attenuation upon binding of ligands. Ligand-RNA binding can be studied by techniques such as 
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isothermal calorimetry. In-line probing, which relies on reduction of RNA cleavage at the 
nucleotides which bind a ligand, can determine where in a sequence a ligand binds. Modulation 
of gene expression via a riboswitch mechanism can be studied in bacteria cells through reporter 
gene assays such as the β-galactosidase assay (Miller Assay). In this assay, the riboswitch gene is 
inserted upstream of a ​lacZ​ operon which includes the gene for the enzyme β-galactosidase. 
Ortho​-Nitrophenyl-β-D-galactoside reacts with β-galactosidase to form a yellow compound, 
ortho​-nitrophenol, which is easily quantifiable by UV-Vis absorbance. Riboswitches are 
indispensable to the progress of biochemistry in that small molecules can be used to covalently 
switch on and off gene expression. Transcription and translation are obligatory for cell survival, 
making targeting these processes a promising antibiotic technique.  
 
From the 1930s to the 1960s, many antibiotics were being discovered. This period saw a 
large number of people cured of previously untreatable, and some fatal, infections. However, 
decades later, antibiotics are causing grave problems in healthcare. People are overusing 
antibiotics, as medication as well as in agriculture. Multidrug-resistant bacteria are emerging 
spreading. There are many factors contributing to this resistance including overpopulation, 
enhanced international migration, increased use of antibiotic drugs, and lack of new antibiotic 
drugs attributable to time-consuming regulations and scarce funding [9]. Mechanisms of 
bacterial resistance include enzymatic modification of antibiotic compounds, cell wall 
modification to inhibit uptake, and transfer (via horizontal gene transfer) of resistance genes 
between bacteria [10]. 
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In designing new antibacterial compounds, it is a challenge to identify pathways to target 
that are critical as well as sufficiently widespread and conserved in bacteria. Many known 
antibiotics bind to the 16S ribosomal RNA component of the bacterial ribosome. Riboswitch 
RNAs are also highly conserved, making them potential candidates for antibiotic drug targets. 
Riboswitch-modulated repression of genes necessary to synthesize or import essential 
metabolites may inhibit bacterial growth or promote bacterial cell death. Riboswitches that bind 
thiamin pyrophosphate, lysine and flavin mononucleotide have all been shown to impede 
bacterial growth via binding of ligand analogs [5]. Additionally, because the genes they regulate 
are involved in fundamental metabolic pathways in certain bacterial pathogens, riboswitches 
which bind guanine may be viable targets for the development of novel antibiotics. 
 
One such guanine-binding riboswitch is the ​xpt-pbuX​ riboswitch in ​B. subtilis​ (Figures 
2-4). This riboswitch has a highly characterized sequence and three-dimensional structure, 
making it a useful scaffold for studying metabolite-binding riboswitches. The ​xpt-pbuX 
riboswitch uses a transcription attenuation mechanism regulates genes crucial to purine 
biosynthesis and transport.  
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 Figure 2 ​Guanine (spheres) bound to ​xpt-pbuX​ riboswitch aptamer domain (sticks). 
Figure adapted from Jain, et al. 2015 [12] 
 
Figure 3 ​Sequence and secondary structure of ​xpt-pbuX​ riboswitch from ​B. subtilis​. 
Circled: nucleotides that undergo reduction of spontaneous cleavage during in-line probing 
reactions containing guanine concentrations above the ​K​D​. Shaded: alternative pairing to form 
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anti-terminator stem when ligand is absent. Asterisks: nucleotides added to facilitate ​in vitro 
transcription. Figure adapted from Breaker, et al. [6] 
 
 
 
 
Figure 4​ Guanine in the binding pocket of the ​xpt-pbuX​ riboswitch aptamer. Black ovals 
represent spaces where guanine could be modified without too much interference with 
RNA-ligand binding. Figure from Kim, et al. [5] 
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Figure 5​ Equilibrium dissociation constants for ​C2​- and ​C6​-modified guanine analogs. 
Figure from Kim, et al. [5] 
 
RNA crystal structures of the ​xpt-pbuX​ riboswitch aptamer domain with guanine bound 
to the binding pocket, as well as RNA-ligand docking software, facilitate guanine analog design. 
Many of the guanine analogs designed by Kim, et al. (Figure 5), notably G4 and G11, do not 
repress growth (determined by OD600 of ​B. subtilis​). However, in-line probing assays indicate 
that these compounds bind relatively tightly to the ​xpt-pbuX​ aptamer. One of the several possible 
reasons for this is low bioavailability, which is proportional to the area under the curve of 
concentration versus time. The metabolites may have difficulty entering the cell or its nucleus, or 
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could be converted to another molecule, making it unable to bind to the highly specific 
riboswitch aptamer sequence. 
 
Guanine is difficult to use in experiments compared to other nucleic acid bases due to its 
very low solubility. One problem with analogs G7 and G15 is their insolubility at concentrations 
near their respective minimum inhibitory concentrations. The attempt by Breaker’s group to 
generate G7- and G15-resistant ​B. subtilis ​strains were not successful due to this insolubility [5]. 
Guanine is sparingly soluble in water and aprotic solvents and insoluble in other common 
solvents such as alcohol, ether, chloroform and benzene. Despite this, guanine and derivatives 
play many roles in biochemical pathways and it is imperative to study them. Since discovery of 
antiviral activity of 9-[(2-hydroxy-ethoxy)methyl]guanine (acyclovir) in the 1960s, synthetic 
chemists have attempted to synthesize and test the effects of many N9-substituted guanine and 
guanosine analogs. Acyclovir and ganciclovir are N9-modified guanine analogs which inhibit 
DNA polymerase and are widely used to treat herpes simplex types one and two, as well as HIV.  
 
In modifying guanine, appropriate protecting groups are necessary as there are five 
nitrogen atoms and one oxygen atom in the molecule. While 2-amino-6-alkoxypurines have been 
used to enhance selectivity for N9-coupling to guanine, O6 diphenylcarbamoylation has also 
been used [2,3]. 
 
Polyethylene glycol (PEG) is a polyether with a variety of applications in manufacturing 
and medicine. PEG-modification (PEGylation) of a drug can render it more effective. 
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PEG-modification improves drug solubility, decreases immunogenicity, increases drug stability 
and retention time, and reduces proteolysis and renal excretion, allowing a reduced dosing 
frequency. PEG is non toxic and can additionally act as a micelle or nanoparticle to aid in 
delivery of a drug compound in the body. Here, progress was made toward modifying guanine 
with a short polyethylene glycol at N9 in order to increase solubility of guanine in common 
solvents and test the N9-PEG-modified guanine as a potential ligand to bind the ​xpt-pbuX 
riboswitch aptamer. 
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MATERIALS AND METHODS 
 
Reporter Gene Assay 
 
A construct encompassing the entire ​xpt-pbuX​ guanine riboswitch was placed in a 
pDG1661 plasmid upstream of a β-galactosidase (​lacZ​)  reporter gene by the Breaker group at 
Yale University. This vector was transformed into the amyE locus of ​B. subtilis​ strain 1A1. Cells 
were grown in glucose minimal media as described previously [11]. β-galactosidase expression 
after incubation with various guanine analogs at 700 µM was measured using standard Miller 
assays [5]. Miller units were calculated using the formula: 1 Miller unit = 
((1000)*Abs420nm)-((1.75)*(Abs550nm)) / (t*v*Abs600nm) where t = time in minutes since 
addition of ​ortho​-Nitrophenyl-β-D-galactoside and v = volume of cell culture in mL. 
 
Kirby Bauer Assay 
 
LB agar plates were prepared with 5 µg/mL chloramphenicol prepared in methanol, as 
described previously [11]. ​B. subtilis​ cells were spread on LB agar plates using glass beads. 
Plates were divided into quadrants and a sterile paper disc containing 10 µL of antibiotic or a 
ligand (5 mM in DMSO) was placed in each quadrant. Plates were grown overnight at 37℃.  
 
 
 
17 
PEGylation of Guanine 
 
 1 2       3 
Scheme 4 ​Synthetic scheme for N9-PEGylation of guanine. 
 
Under inert conditions, a stirred suspension of  236.1 mg (1 mmol) of 
2-N,9-diacetylguanine in 348 µL of EtN(i-Pr)​2​ and 4.8 mL of dry (distilled with KOH and 
molecular sieves) pyridine was treated  with 257 mg (1.1 mmol) of  Ph​2​NCOCl for 1 h at 
ambient temperature. H​2​O (400 µL) was added and stirring continued for 10 min. Evaporation ​in 
vacuo​ was followed by heating (with reflux) the residue with 12 mL of 50% EtOH/H2O for 1.5 
h. Cooling, vacuum filtration, washing (EtOH), and drying gave 179 mg (46%) of  ​1​. ​1​H NMR 
sample was prepared in DMSO-​d​6​ and 16 scans were run. 
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70.66 mg (0.269 mmol) of triphenylphosphine was added to a two-neck round bottom 
flask with a condenser, under inert conditions. 43.12 µL (0.269 mmol) of triethylene glycol 
monomethyl ether was added. Solution was stirred. 100 mg (0.257 mmol) of ​1​ dissolved in 4.7 
mL of anhydrous THF was added. 53.05 µL (0.269 mmol) of diisopropyl azodicarboxylate was 
added. Reaction refluxed and stirred at 70℃ for 6 h. A second equivalent of triethylene glycol 
monomethyl ether, triphenylphosphine, and diisopropyl azodicarboxylate were added. Reaction 
refluxed and stirred at 70℃ for 6 h. Reaction was cooled and poured into 6 mL of saturated NaCl 
solution. Mixture was extracted with dichloromethane (11 mL x 3). Combined organic layers 
were washed (H​2​O) and dried (magnesium sulfate). Evaporation ​in vacuo​ gave 362 mg crude ​2​. 
1​H NMR sample was prepared in DMSO-​d​6​ and 16 scans were run. Yield cannot be determined. 
Analysis of ​2​ (dissolved in ethyl acetate) by TLC was performed using 0.5:1.5:8 
H​2​O/H​3​COH/ethyl acetate. 
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RESULTS 
 
Reporter Gene Assay 
 
Miller assay was performed to quantify β-galactosidase production. If a ligand is bound 
to the riboswitch aptamer domain (Scheme 1 and Figure 2), the expression platform will adopt 
the “off” configuration, impeding RNA polymerase and switching off transcription of the 
downstream genes. Because the riboswitch gene was inserted upstream of the gene encoding 
β-galactosidase production, less β-galactosidase should be produced by those cells treated with 
ligands capable of binding to the riboswitch’s aptamer domain. Figure 6 shows relative Miller 
units, proportional to absorbance of 420 nm light and therefore production of β-galactosidase, for 
different guanine analog ligands. All ligands show less β-galactosidase production than the 
control, DMSO. It is impossible, from these results alone, to determine the mechanism of 
inhibition of β-galactosidase production by the ligands. However, these results can be used as 
evidence to support the riboswitch mechanism of transcription attenuation.  
 
These results are not in agreement with literature in that guanine normally decreases 
β-galactosidase production by at least 80% compared to the control when tested in this assay  [5, 
11, 12]. Additionally, 6-thioguanine is known to incorporate itself into DNA as a base and is 
toxic to cells [7]. Therefore, it is possible that the low β-galactosidase production by cells 
incubated with 6-thioguanine is due to this toxicity, rather than the binding of 6-thioguanine to 
the riboswitch aptamer. 
20 
  
Figure 6 ​β-galactosidase expression for ​B. subtilis​ following incubation with purine 
ligands (700 µM) normalized to expression observed with DMSO. Error bars represent standard 
error between replicates (n​DMSO​=5; n​guanine​=3; n​guanosine​=5; n​thioguanine​=4). 
 
Kirby Bauer Assay 
 
Kirby Bauer disc assay was performed to assess cell growth inhibition by various guanine 
analogs (Figure 7). While the Miller assay gave information regarding gene expression, the 
21 
Kirby Bauer assay was done to look for any effect of the ligands on bacterial growth, as well as 
any correlation between gene expression inhibition and growth inhibition. None of the guanine 
analogs showed any zones of inhibition around the discs, implying that bacterial growth was not 
impeded. Taken with the results of the Miller assay, it can be concluded that reduction of 
β-galactosidase expression does not necessarily lead to growth inhibition. For both guanine and 
6-thioguanine, β-galactosidase expression was reduced in presence of the ligand although cell 
growth was not. Therefore, the cell can recuperate and grow normally even when β-galactosidase 
production is hindered. 
 
  
Figure 7​ Kirby Bauer disc assay. N: Neomycin Trisulfate Salt Hydrate antibiotic (Zone 
of inhibition = 1 cm). T: Thioguanine. D: DMSO. G: Guanine. All compounds at 5 mM. 
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PEGylation of Guanine 
 
1​H NMR of the starting material, 2-N,9-diacetylguanine, was taken to verify its identity 
(Figure 8). The peaks and integrations are in agreement with literature values [4, 14].  
 
 
Figure 8 ​1​H NMR spectrum (400 MHz, DMSO-​d​6​) of starting material, 
2-N,9-diacetylguanine: white solid. δ 2.17 (s, 3H, C13-H​3​), 2.78 (s, 3H, C16-H​3​), 8.42 (s, 1H, 
H-8), 11.53 (s, 1H, N10-H), 11.99 (s, 1H, N1-H). 
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 1​H NMR was performed to verify formation of ​1​ (Figure 9). Peaks and integrations are 
consistent with literature values [4, 13]. The appearance of a broad singlet at 13.53 ppm is 
evidence of the removal of the acetyl group from the N9 position of 2-N,9-diacetylguanine. 
Additionally, the appearance of two multiplets, integrating to ten hydrogens, confirms the 
presence of the diphenyl group. It is possible that the peaks at 11.92 ppm and 12.08 ppm are the 
N1-H from the starting material [14].  
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 Figure 9 ​1​H NMR spectrum (400 MHz, DMSO-​d​6​) of ​1​: purple solid. δ 2.12 (s, 3H, 
CH​3​), 7.25-7.45 (m, 10H, Ph​2​), 8.37 (s, 1H, H-8), 10.60 (s, 1H, H-10), 13.53 (s, 1H, H-9). 
 
1​H NMR was performed to verify formation of ​2​ (Figure 10). Loss of the singlet at 13.53 
ppm (Figure 9) suggests that the polyethylene glycol was attached at the N9 position. It is 
unclear if peaks at 10.25 ppm and 8.50 ppm are from ​1​, or if they are something else. The exact 
shifts do not show peaks in the 1H NMR spectrum of ​1​ (Figure 9). The C6-H peak could not be 
identified. It is most likely masked by the phenyl proton peaks in the 7.0-7.25 ppm range.  
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 Figure 10​ ​1​H NMR spectrum (400 MHz, DMSO-​d​6​) for ​2​: yellow oil. δ 2.20 (s, 3H, 
C13-H), 3.17 (s, 3H, OCH​3​), 3.36-3.62 (m, 8H, 2x CH​2​OCH​2​), 3.82 (t, 2H, CH​2​CH​2​N), 4.34 (t, 
2H, CH​2​OCH​3​), 7.4-7.7 (m, 10H, Ph​2​), 8.88 (s, 1H, H-8), 10.68 (s, 1H, N10-H). 
 
Chromatography 
 
In order to purify ​2​, a silica column was run in a micropipet with 0.5:1.5:8 
water/methanol/ethyl acetate. This solvent system was chosen due to solubility of the crude 
material in this system as well as the clear separation afforded via TLC. Fractions were collected 
and spotted on TLC plates next to the crude material in order to identify components of the crude 
product (Figure 11). Six clear spots were visible in the TLC of the crude material, meaning there 
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are six different compounds present. The top three spots (the three least polar compounds) were 
collected in the 18 fractions. While running the column, no apparent bands were visible moving 
down the silica. Most likely, the three bottom spots of the crude material (the three most polar 
compounds) were stuck on the polar silica of the column.  
 
 
Figure 11​: TLC separation of ​2 (​dissolved in ethyl acetate). Eluent: 0.5:1.5:8 
H​2​O/H​3​COH/ethyl acetate. C: crude ​2​, pre-column. ​Rf​ compound 1: 0.90 (Fractions 5-7); ​Rf 
compound 2: 0.68 (Fractions 11-13); ​Rf​ compound 3: 0.45 (Fractions 15-18).  
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DISCUSSION 
 
Reporter Gene Assay 
 
Miller assay results varied greatly, which could be a result of poor solubility of the 
ligands. The assay should be repeated with much lower concentrations of ligands. This could 
also be the result of biofilm formation in the ​B. subtilis​ cultures. The cells are grown in growth 
minimal media, spiked with ligands, which may cause the cells stress, leading to biofilm 
formation. This poses a problem in transferring the cells from the test tube to the microcentrifuge 
tube used for the assay because it is very difficult to not bring up any of the biofilm into the 
pipet. In the future, this problem should be further investigated. If biofilm production can be 
prohibited, the amount of cells in each tube would be more uniform.  
 
Kirby Bauer Assay 
 
Fractions from the micropipet column (Figure 11) should be analyzed by ​1​H NMR to 
determine the identity of each compound. Additionally, another silica column with the same 
eluent should be run on a much larger scale as the minute fractions were difficult to work with. 
When proper separation of all six compounds present in the crude ​2 ​is achieved, more ​2 ​should 
be generated and flash chromatography should be employed. This could give much better 
purification than running a silica column by hand. After this purification, ​2​ would be verified 
again via TLC and ​1​H NMR to be sure there is nothing else present. 
28 
 Upon purifying ​2​, the final deprotection step (Scheme 4) can be performed via reflux in 
ammonia/methanol to afford crude ​3​. The protocol, adapted from the N9-alkylation protocol of 
Ciesielski et al., calls for a final purification via silica gel [15]. This could also potentially be 
done by flash chromatography after preliminary TLC analysis and subsequent micropipet 
column using a small amount of crude ​3​. 
 
Considering the three-dimensional structures of the riboswitch, it is possible that the 
N9-PEGylated guanine may not bind as tightly as guanine to the binding pocket of the ​xpt-pbuX 
riboswitch due to steric hindrance. Figure 4 shows optimal positions for modification, which do 
not include the N9 position. However, x-ray crystal structures misrepresent the aptamer domain 
of the riboswitch as being static, when it is in fact flexible and capable of rearrangement. This, in 
conjunction with the free rotation about the sigma bonds of polyethylene glycol, make it 
plausible for the N9-PEGylated guanine to stick to the binding pocket of the ​xpt-pbuX​ riboswitch 
aptamer domain. Future studies of this PEGylated analog should include ​in vivo​ β-galactosidase 
assay as well as ​in vitro​ binding studies with the purified ​xpt-pbuX​ aptamer domain. Binding 
studies can provide a ​K​D​ ​value for PEGylated guanine, while the β-galactosidase assay will 
expose repression of gene expression, whether through this riboswitch mechanism or another 
pathway. In-line probing could also be done with this new analog. 
  
 The most important applications of riboswitches are creation of ligand-controlled genetic 
constructs, design of new ligand analogs for natural riboswitches, and engineering of designer 
29 
riboswitches. ​Xpt-pbuX​ riboswitch is a viable model system for riboswitch-mediated control of 
transcription and gene expression. However, ​B. subtilis​ is not known to cause disease. These 
methods should be used to study repression of gene expression and bacterial growth in 
pathogenic bacteria, especially those which show resistance to broad-spectrum antibiotics. 
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